BIOMAT Database Logo BIOMAT Database Logo

Alpha-interferon in a case of hypereosinophilic syndrome. 1991

P J van den Anker-Lugtenburg, and M B van 't Veer

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D008297 Male Males
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004802 Eosinophilia Abnormal increase of EOSINOPHILS in the blood, tissues or organs. Eosinophilia, Tropical,Hypereosinophilia,Tropical Eosinophilia,Hypereosinophilias,Tropical Eosinophilias
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

P J van den Anker-Lugtenburg, and M B van 't Veer
Alpha interferon for hypereosinophilic syndrome.
December 1994, American journal of hematology,
P J van den Anker-Lugtenburg, and M B van 't Veer
Alpha-interferon for the hypereosinophilic syndrome.
February 1991, Annals of internal medicine,
P J van den Anker-Lugtenburg, and M B van 't Veer
Interferon-alpha for the hypereosinophilic syndrome.
November 1990, Annals of internal medicine,
P J van den Anker-Lugtenburg, and M B van 't Veer
Alfa-interferon in a case of hypereosinophilic syndrome.
August 1990, British journal of haematology,
P J van den Anker-Lugtenburg, and M B van 't Veer
alpha-Interferon treatment for idiopathic hypereosinophilic syndrome.
March 1994, American journal of hematology,
P J van den Anker-Lugtenburg, and M B van 't Veer
Treatment of the hypereosinophilic syndrome with interferon-alpha.
July 1995, Annals of internal medicine,
P J van den Anker-Lugtenburg, and M B van 't Veer
[Interferon-alpha therapy in the myeloproliferative variants of hypereosinophilic syndrome].
March 1993, [Rinsho ketsueki] The Japanese journal of clinical hematology,
P J van den Anker-Lugtenburg, and M B van 't Veer
Effective long-term alpha-interferon treatment for hypereosinophilic syndrome.
July 1995, The Journal of allergy and clinical immunology,
P J van den Anker-Lugtenburg, and M B van 't Veer
Sustained remission of idiopathic hypereosinophilic syndrome following alpha-interferon therapy.
January 1993, Acta haematologica,
P J van den Anker-Lugtenburg, and M B van 't Veer
Complete remission of hypereosinophilic syndrome after interferon-alpha therapy: report of a case and literature review.
February 2000, The Journal of dermatology,
Copied contents to your clipboard!